Tirzepatide vs. Conventional Care for Early Type 2 Diabetes Management
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Study Design
Population
Patients with early Type 2 Diabetes.
Comparator
Conventional care.
Outcome
Not specified in the digest.
Abstract
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diab…